DGIdb - IRESSA Drug Record

IRESSA wikidata:Q29006033

Alternate Names:

rxcui:281883

Drug Info:

(0 More Sources)

Publications:

Henic et al., 2006, EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor., Gynecol. Oncol.
Piechocki et al., 2006, Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu., Int. J. Cancer

IRESSA PLAU

Interaction Score: 2.38

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16263158

Sources:
NCI
IRESSA ERBB2

Interaction Score: 0.42

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
16470840

Sources:
NCI

NCI: IRESSA

Version: 14-September-2017

Alternate Names:

C1855 NCI drug code

Drug Info:

Publications:

Henic et al., 2006, EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor., Gynecol. Oncol.

Piechocki et al., 2006, Iressa induces cytostasis and augments Fas-mediated apoptosis in acinic cell adenocarcinoma overexpressing HER2/neu., Int. J. Cancer

Wikidata: wikidata:Q29006033
- Version: 12-August-2020
Alternate Names:

Drug Info:

Publications: